The Effect of Exercise Intervention on Insulin Resistance in Non-alcoholic Fatty Liver Disease (NAFLD)
The Effects of Exercise Training on Visceral Fat, Insulin Sensitivity, Β-cell Function and Triglyceride Kinetics in Patients with Non-alcoholic Fatty Liver Disease (NAFLD).
1 other identifier
interventional
60
1 country
7
Brief Summary
This project examines the effects of a 4 month structured exercise intervention program in patients with non-alcoholic fatty liver disease (NAFLD). We will examine changes in total and depot-specific (i.e.in different tissues, liver, muscle and pancreas)fat. We will correlate these with measurements of the insulin from the liver. The hypothesis is that by reducing fat in these specific depots we can reduce insulin resistance and prevent progression to diabetes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2009
Longer than P75 for not_applicable
7 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2013
CompletedFirst Submitted
Initial submission to the registry
April 12, 2013
CompletedFirst Posted
Study publicly available on registry
April 17, 2013
CompletedDecember 18, 2024
May 1, 2024
4.2 years
April 12, 2013
December 13, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Reduction in liver and muscle fat
Tissue triglyceride content, or steatosis, will be accurately and non-invasively quantified in vivo using localized proton magnetic resonance spectroscopy (1H MRS).
4 months
Secondary Outcomes (5)
Changes in liver function tests
4 months
Changes in lipid profiles
4 months
Changes in body weight and anthropometric measurements
4 months
Hepatic insulin sensitivity
4 months
VLDL-TG kinetics
4 months
Study Arms (2)
Control
EXPERIMENTALUnsupervised exercise training This group will be given 1 hour lifestyle counseling by the exercise trainer after which they will have no contact with the exercise trainer to the end of the intervention period. The exercise intervention will be offered to the subjects once the post studies are completed.
lifestyle counseling and exercise
EXPERIMENTALSupervised exercise training Four months exercise training intervention will be either gym-based or patients will choose the mode of exercise that suits their lifestyle. Patients will be encouraged to exercise four times per week for 30-45 min at 60-80 % of maximal heart rate, with a 5 min warm-up and warm-down. Participants will be given free access to a variety of affiliated sports centres and will use the Wellness Key system, a software program that enables researchers to remotely track the exercise activity of participants very accurately. To ensure compliance with rest or exercise, all participants of both groups will have their mean physical activity level in 2 non-consecutive weeks evaluated with an ambulatory accelerometer.
Interventions
The patients will be given lecture on lifestyle changes and its benefitial effects on health at the begining of the study by the exercise trainer. There will be no conatct with the exercise trainer for the period of intervention for 4 months.
Patients will be encouraged to exercise four times per week for 30-45 min at 60-80 % of maximal heart rate, with a 5 min warm-up and warm-down. Participants will be given free access to a variety of affiliated sports centres and will use the Wellness Key system, a software program that enables researchers to remotely track the exercise activity of participants very accurately. To ensure compliance with rest or exercise, all participants of both groups will have their mean physical activity level in 2 non-consecutive weeks evaluated with an ambulatory accelerometer.
Eligibility Criteria
You may qualify if:
- Sedentary, non smoking, male subjects,
- Alcohol consumption men \<21 units/week,
- BMI 27-35. (Lean individuals do not suffer from NAFLD, so are not suitable for this study. Conversely, we are restricted to a maximum BMI of 35 due to the size limitations of the MR scanner.)
- Being willing to engage and motivated to follow an exercise program.
You may not qualify if:
- Prescription of corticosteroids, amiodarone, tamoxifen, methotrexate (drugs known to cause secondary steatohepatitis) or fibrates. Statin is Ok as long as the patients are on stable therapy for a while, if changed then the patient will be excluded.
- Alcohol consumption for men 21 units/week.
- A contraindication to exercise (such as unstable ischaemic heart disease),
- Type 2 diabetes (type 2 diabetes patients are excluded so that we are examining the involvement of insulin resistance at a reversible stage before β-cell failure has occurred).
- Patients who are on medications that will interact with GTN (glyceryl trinitrate) will be excluded from the GTN dilatation (endothelial independent NO mediated function) aspect of the study.
- Individuals who suffer from claustrophobia and have metal implants will be excluded from the MRI aspect of the study.
- Patients who smoke will also be excluded from the study.
- Total cholesterol \>7
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Liverpoollead
- Royal Liverpool University Hospitalcollaborator
- University of Surreycollaborator
- Imperial College Londoncollaborator
- Royal Surrey County Hospital NHS Foundation Trustcollaborator
Study Sites (7)
Royal Surrey County Hospital
Guildford, Surrey, GU16 7UJ, United Kingdom
University of Surrey
Guildford, Surrey, GU27WG, United Kingdom
John Moores University
Liverpool, L3 2ET, United Kingdom
University of Liverpool
Liverpool, L69 3GE, United Kingdom
Royal Liverpool University Hospital
Liverpool, L7 8XP, United Kingdom
Liverpool University
Liverpool, L9 7AL, United Kingdom
Imperial College London
London, W12 0HS, United Kingdom
Related Publications (2)
Shojaee-Moradie F, Cuthbertson DJ, Barrett M, Jackson NC, Herring R, Thomas EL, Bell J, Kemp GJ, Wright J, Umpleby AM. Exercise Training Reduces Liver Fat and Increases Rates of VLDL Clearance But Not VLDL Production in NAFLD. J Clin Endocrinol Metab. 2016 Nov;101(11):4219-4228. doi: 10.1210/jc.2016-2353. Epub 2016 Sep 1.
PMID: 27583475DERIVEDPugh CJ, Sprung VS, Jones H, Richardson P, Shojaee-Moradie F, Umpleby AM, Green DJ, Cable NT, Trenell MI, Kemp GJ, Cuthbertson DJ. Exercise-induced improvements in liver fat and endothelial function are not sustained 12 months following cessation of exercise supervision in nonalcoholic fatty liver disease. Int J Obes (Lond). 2016 Dec;40(12):1927-1930. doi: 10.1038/ijo.2016.123. Epub 2016 Jul 21.
PMID: 27439593DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Daniel Cuthbertson, BSc PhD MRCP
University of Liverpool
- PRINCIPAL INVESTIGATOR
Fariba Shojaee-Moradie, BSc PhD
University of Surrey
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 12, 2013
First Posted
April 17, 2013
Study Start
January 1, 2009
Primary Completion
April 1, 2013
Study Completion
April 1, 2013
Last Updated
December 18, 2024
Record last verified: 2024-05